PRA Health Sciences, Inc

(NASDAQ:PRAH)

Latest On PRA Health Sciences, Inc (PRAH):

Date/Time Type Description Signal Details
2021-03-03 12:17 ESTAnalyst RatingThe Analyst Target Price has increased from $144.7 to $147.4.Buy
2021-03-01 12:12 ESTAnalyst RatingThe Analyst Target Price has increased from $139.4 to $144.7.Neutral
2021-02-27 00:27 ESTNewsPRA Health Sciences, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-02-26 16:11 ESTAnalyst RatingThe Analyst Target Price has increased from $127.42 to $139.4.Neutral
2021-02-25 21:46 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 14:18 ESTEarnings EstimateAn EPS average of $1.41 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 14:18 ESTEarnings EstimateAn EPS average of $6.62 is estimated for the 2022 year.Buy
2021-02-24 13:09 ESTNewsPRA Health Sciences EPS beats by $0.09, beats on revenueN/A
2021-02-24 13:09 ESTNewsICON to acquire PRA Health in a cash and stock deal valued at $12BN/A
2021-02-24 13:08 ESTNewsLabCorp sum-of-the-parts worth $313/share with activist push, analyst saysN/A
2021-02-24 13:08 ESTNewsWilliam Blair sees 'very complementary fit' with ICON acquisition of PRA HealthN/A
2021-01-27 08:18 ESTAnalyst RatingThe Analyst Target Price has increased from $126.75 to $127.42.Neutral
2021-01-21 12:33 ESTAnalyst RatingThe Analyst Target Price has increased from $125.5 to $126.75.Neutral
2021-01-13 08:25 ESTAnalyst RatingThe Analyst Target Price has increased from $125.17 to $125.5.Neutral
2021-01-11 12:28 ESTAnalyst RatingThe Analyst Target Price has increased from $124.75 to $125.17.Neutral
2021-01-08 12:25 ESTAnalyst RatingThe Analyst Target Price has increased from $122.92 to $124.75.Neutral
2020-12-03 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $122.77 to $122.92.Buy
2020-11-26 21:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 05:08 ESTAnalyst RatingThe Analyst Target Price has increased from $121.23 to $122.77.Buy
2020-11-11 04:45 ESTAnalyst RatingThe Analyst Target Price has increased from $119.62 to $121.23.Buy
2020-11-09 20:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 13:06 ESTAnalyst RatingThe Analyst Target Price has increased from $117.23 to $119.62.Buy
2020-11-08 00:39 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 14:59 ESTNewsPRA Health Sciences, Inc. 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-07 14:58 ESTNewsPRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-06 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $114.38 to $117.23.Buy
2020-11-05 13:05 ESTNewsPRA Health Sciences EPS beats by $0.16, beats on revenue; FY20 guidanceN/A
2020-11-05 13:00 ESTEarnings EstimateAn EPS average of $1.27 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-05 12:59 ESTAnalyst RatingThe Analyst Target Price has increased from $113.77 to $114.38.Neutral
2020-10-30 14:20 ESTAnalyst RatingThe Analyst Target Price has increased from $113.46 to $113.77.Buy
2020-10-08 10:00 ESTAnalyst RatingThe Analyst Target Price has increased from $113.23 to $113.46.Buy
2020-10-06 09:50 ESTAnalyst RatingThe Analyst Target Price has decreased from $113.62 to $113.23.Neutral
2020-09-26 13:47 ESTFinancialsCompany financials have been released.Neutral
2020-09-22 05:57 ESTNewsPRA Health Sciences: A Solid Investment Case But Watch Out For Signs Of InertiaN/A
2020-09-18 14:53 ESTNewsPRA Health and Deep Lens partner to accelerate patient recruitmentN/A
2020-09-17 05:53 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 17:43 ESTInsider TradeGlen D. Stettin has directly acquired 799 shares and currently holds 799 shares.Buy
2020-08-17 16:30 ESTInsider TradeMichael J. Bonello has directly disposed of 2,052 shares and currently holds 21,276 shares.Sell
2020-08-17 16:30 ESTInsider TradeChristopher L Gaenzle has directly disposed of 1,364 shares and currently holds 37,636 shares.Sell
2020-08-17 16:30 ESTInsider TradeCOLIN SHANNON has directly disposed of 6,073 shares and currently holds 56,927 shares.Sell
2020-08-14 09:51 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:51 ESTAnalyst RatingThe Analyst Target Price has increased from $113.31 to $113.62.Buy
2020-08-11 21:40 ESTAnalyst RatingThe Analyst Target Price has increased from $111.92 to $113.31.Buy
2020-08-10 09:34 ESTAnalyst RatingThe Analyst Target Price has increased from $106.77 to $111.92.Buy
2020-08-09 13:32 ESTFinancialsCompany financials have been released.Neutral
2020-08-08 01:19 ESTNewsPRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-08 01:19 ESTNewsPRA Health Sciences, Inc. 2020 Q2 - Results - Earnings Call PresentationN/A
2020-08-07 00:41 ESTNewsPRA Health Sciences EPS beats by $0.04, beats on revenueN/A
2020-08-06 21:39 ESTFinancialsCompany financials have been released.Neutral

About PRA Health Sciences, Inc (PRAH):

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company has a partnership with The Leukemia & Lymphoma Society to launch a clinical trial for developing treatments for children with relapsed acute leukemia. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.

See Advanced Chart

General

  • Name PRA Health Sciences, Inc
  • Symbol PRAH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 18,100
  • Fiscal Year EndDecember
  • IPO Date2014-11-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryLife Sciences Tools & Services
  • Gic SubIndustryLife Sciences Tools & Services
  • Web URLhttp://prahs.com
View More

Valuation

  • Trailing PE 46.99
  • Forward PE 24.63
  • Price/Sales (Trailing 12 Mt.) 2.95
  • Price/Book (Most Recent Quarter) 6.32
  • Enterprise Value Revenue 3.24
  • Enterprise Value EBITDA 23.77
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $5.95
  • Next Year EPS Estimate $6.81
  • Next Quarter EPS Estimate $1.32
  • Profit Margin 6%
  • Operating Margin 9%
  • Return on Assets 5%
  • Return on Equity 15%
  • Revenue 3.18 billion
  • Earnings Per Share $3.04
  • Revenue Per Share $50.25
  • Gross Profit 1.53 billion
  • Quarterly Earnings Growth 9.1%
View More

Highlights

  • Market Capitalization 9.22 billion
  • EBITDA 415.57 million
  • PE Ratio 46.51
  • PEG Ratio 2.74
  • Analyst Target Price $147.4
  • Book Value Per Share $22.92
View More

Share Statistics

  • Shares Outstanding 64.54 million
  • Shares Float 64.37 million
  • % Held by Insiders 24%
  • % Held by Institutions 98.91%
  • Shares Short 748886
  • Shares Short Prior Month 792152
  • Short Ratio 2.72
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.27
  • 52 Week High $150.82
  • 52 Week Low $58.67
  • 50 Day Moving Average 130.45
  • 200 Day Moving Average 114.94
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

PRA Health Sciences, Inc (PRAH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

PRA Health Sciences, Inc (PRAH) Earnings Estimates:

An earnings estimate is an analyst's estimate for a company's future quarterly or annual earnings per share (EPS). Future earnings estimates are arguably the most important data when attempting to value a firm.

PRAH's EPS estimate for the current year is $5.95
Date Number of Analysts Average Estimate Low Estimate High Estimate
2021-03-3110$1.27$1.17$1.37
2021-06-3010$1.41$1.30$1.50

PRA Health Sciences, Inc (PRAH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

PRAH's next estimated earnings release date is April 30, 2021.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$1.55$1.466.46%
2020-09-302020-11-04$796.28 million$1.30$1.1414.07%
2020-06-302020-08-06$N/A$0.86$0.824.5%
2020-03-312020-04-30$N/A$1.05$1.005.34%
2019-12-312020-02-20$800.24 million$1.54$1.474.63%
2019-09-302019-10-30$780.69 million$1.32$1.292.31%
2019-06-302019-07-31$763.31 million$1.22$1.174.09%
2019-03-312019-05-01$722.02 million$1.10$1.063.65%
2018-12-312019-02-27$729.65 million$1.31$1.273.28%
2018-09-302018-10-31$717.6 million$1.13$1.075.27%
2018-06-302018-08-01$722.84 million$1.00$0.955.35%
2018-03-312018-04-25$701.84 million$0.85$0.841.52%
2017-12-312018-02-21$655.9 million$1.04$1.021.49%
2017-09-302017-10-25$582.01 million$0.88$0.853.98%
2017-06-302017-08-07$533.72 million$0.79$0.746.54%
2017-03-312017-04-25$487.76 million$0.62$0.603.14%
2016-12-312017-02-22$472.39 million$0.71$0.6410.71%
2016-09-302016-11-02$453.26 million$0.64$0.630.87%
2016-06-302016-07-28$455.85 million$0.63$0.597.47%
2016-03-312016-04-27$430.22 million$0.55$0.533.79%
2015-12-312016-02-24$428.95 million$0.59$0.5017.02%
2015-09-302015-11-02$403.51 million$0.52$0.4515.56%
2015-06-302015-07-27$392.85 million$0.47$0.4017.5%
2015-03-312015-05-06$388.58 million$0.41$0.3132.26%
2014-12-312015-02-18$369.96 million$0.35$0.3016.67%

PRA Health Sciences, Inc (PRAH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

PRA Health Sciences, Inc (PRAH) Chart:

PRA Health Sciences, Inc (PRAH) News:

Below you will find a list of latest news for PRA Health Sciences, Inc (PRAH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

PRA Health Sciences, Inc (PRAH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2021-03-19650CALL 301.79TRUE00
2021-03-19700CALL 155.58TRUE00
2021-03-19750CALL 141.68TRUE00
2021-03-19800CALL 128.65TRUE00
2021-03-19850CALL 123.13TRUE00
2021-03-19900CALL 110.93TRUE00
2021-03-199529.4CALL1 199.33TRUE3.010.11
2021-03-191000CALL 88.24TRUE00
2021-03-191050CALL 72.96TRUE00
2021-03-191100CALL 63.18TRUE00
2021-03-191150CALL 48.51TRUE00
2021-03-1912028.2CALL20 850.21TRUE17.71.69
2021-03-1912522.5CALL1 142.17TRUE-2.4-0.1
2021-03-191303.9CALL10 836.96TRUE-0.31-0.07
2021-03-191351.85CALL4 831.67TRUE-0.2-0.1
2021-03-1914011.2CALL1 426.27TRUE9.324.96
2021-03-191453.4CALL2 231.08FALSE3.40
2021-03-191501.23CALL3 1646.35FALSE-1.07-0.47
2021-03-191550.2CALL5 36726.75FALSE-0.5-0.71
2021-03-191600.6CALL4 736.21FALSE-1-0.63
2021-03-191650.05CALL1 560FALSE-0.85-0.94
2021-03-191700CALL 0FALSE00
2021-03-191750CALL 0FALSE00
2021-03-191800.15CALL8 585.48FALSE0.150
2021-03-191850CALL 0FALSE00
2021-03-191900.05CALL2 210FALSE00
2021-03-191950.05CALL2 590FALSE-0.15-0.75
2021-03-19650PUT 0FALSE00
2021-03-19700PUT 0FALSE00
2021-03-19750PUT 0FALSE00
2021-03-19800PUT 0FALSE00
2021-03-19850PUT 0FALSE00
2021-03-19900PUT 0FALSE00
2021-03-19950.02PUT2 20FALSE0.020
2021-03-191000PUT 0FALSE00
2021-03-191050PUT 0FALSE00
2021-03-191100PUT 0FALSE00
2021-03-191150PUT 0FALSE00
2021-03-191200.15PUT8 5198.69FALSE-0.05-0.25
2021-03-191250.35PUT2 40FALSE-4.05-0.92
2021-03-191300.4PUT336 35938.62FALSE-0.05-0.11
2021-03-191350.2PUT2 6547.78FALSE-0.05-0.2
2021-03-191401.45PUT12 12723.85FALSE0.10.07
2021-03-191453.29PUT2 1323.94TRUE1.490.83
2021-03-191506PUT8 822.78TRUE0.90.18
2021-03-1915511PUT1 129.42TRUE4.40.67
2021-03-1916013.2PUT1 227.56TRUE5.60.74
2021-03-1916519PUT1 133.78TRUE30.19
2021-03-191700PUT 39.67TRUE00
2021-03-191750PUT 99.37TRUE00
2021-03-191800PUT 50.6TRUE00
2021-03-191850PUT 55.73TRUE00
2021-03-191900PUT 60.65TRUE00
2021-03-191950PUT 126.49TRUE00
2021-04-16500CALL 128.77TRUE00
2021-04-16550CALL 133.35TRUE00
2021-04-16600CALL 165.85TRUE00
2021-04-16650CALL 111.66TRUE00
2021-04-16700CALL 160.18TRUE00
2021-04-16750CALL 86.29TRUE00
2021-04-168028CALL2 178.41TRUE4.70.2
2021-04-16850CALL 70.98TRUE00
2021-04-169063.88CALL2 463.94TRUE36.861.36
2021-04-169520.5CALL1 257.24TRUE20.50
2021-04-161000CALL 50.85TRUE00
2021-04-161050CALL 46.86TRUE00
2021-04-1611021.35CALL1 340.71TRUE3.450.19
2021-04-161158.4CALL4 1136.21TRUE-0.7-0.08
2021-04-1612031.3CALL3 10730.21TRUE17.371.25
2021-04-161257.6CALL1 131.76TRUE-0.5-0.06
2021-04-1613022CALL1 228.89TRUE0.50.02
2021-04-161353.5CALL1 124.77TRUE3.50
2021-04-1614011.7CALL13 2922.32TRUE8.953.25
2021-04-161452CALL4 1221.62FALSE0.750.6
2021-04-161506CALL10 1229.77FALSE5.196.41
2021-04-161552CALL1 225.56FALSE-1.52-0.43
2021-04-161600CALL 40.94FALSE00
2021-04-161650.01CALL1 747.28FALSE-1.69-0.99
2021-04-161701.15CALL3 20FALSE1.150
2021-04-161750CALL 0FALSE00
2021-04-161800CALL 0FALSE00
2021-04-161850CALL 0FALSE00
2021-04-161900CALL 0FALSE00
2021-04-161950CALL 0FALSE00
2021-04-162000CALL 0FALSE00
2021-04-16500.52PUT4 20FALSE-1.57-0.75
2021-04-16550PUT 0FALSE00
2021-04-16603.46PUT1 10FALSE3.45345
2021-04-16652.44PUT4 0FALSE2.440
2021-04-16702.46PUT9 60FALSE0.010
2021-04-16753.46PUT2 10FALSE3.460
2021-04-16800PUT 40FALSE00
2021-04-16850PUT 0FALSE00
2021-04-16903.55PUT221 1030FALSE-4.55-0.56
2021-04-16950PUT 0FALSE00
2021-04-161002.1PUT2 30FALSE-2.71-0.56
2021-04-161050PUT 0FALSE00
2021-04-161104.08PUT10 100FALSE-3.12-0.43
2021-04-1611510.5PUT10 100FALSE10.50
2021-04-161200.8PUT2 1556.98FALSE-6.6-0.89
2021-04-161256.5PUT11 1147.66FALSE6.50
2021-04-161300PUT 41.3FALSE00
2021-04-161351.05PUT7 2429.95FALSE-10.75-0.91
2021-04-161401.7PUT1 122.63FALSE1.70
2021-04-161454.9PUT2 219.16TRUE00
2021-04-161507.25PUT5 519.56TRUE2.170.43
2021-04-161558.61PUT6 219.4TRUE8.610
2021-04-1616012.5PUT1 121.83TRUE12.50
2021-04-161650PUT 21.62TRUE00
2021-04-161700PUT 26.92TRUE00
2021-04-161750PUT 30.55TRUE00
2021-04-161800PUT 61.54TRUE00
2021-04-161850PUT 65.35TRUE00
2021-04-161900PUT 35.17TRUE00
2021-04-161950PUT 37.92TRUE00
2021-04-162000PUT 40.58TRUE00
2021-07-16600CALL 65.99TRUE00
2021-07-16650CALL 60.32TRUE00
2021-07-16700CALL 52.74TRUE00
2021-07-16750CALL 48.02TRUE00
2021-07-16800CALL 47.26TRUE00
2021-07-16850CALL 44.16TRUE00
2021-07-16900CALL 38.6TRUE00
2021-07-169522.4CALL1 134.6TRUE22.40
2021-07-161000CALL 34.39TRUE00
2021-07-161050CALL 33.98TRUE00
2021-07-161100CALL 31.15TRUE00
2021-07-161150CALL 29.16TRUE00
2021-07-1612031.2CALL1 2428.53TRUE161.05
2021-07-161250CALL 25.01TRUE00
2021-07-1613024CALL2 3122.75TRUE0.10
2021-07-161350CALL 21.01TRUE00
2021-07-1614014.65CALL1 920.03TRUE7.731.12
2021-07-161450CALL 619.08FALSE00
2021-07-161509.12CALL4 518.14FALSE4.220.86
2021-07-161556.6CALL2 222.65FALSE6.60
2021-07-161601.55CALL1 223.28FALSE-4.95-0.76
2021-07-161650CALL 26.86FALSE00
2021-07-161701.8CALL1 230.09FALSE1.80
2021-07-161750CALL 32.99FALSE00
2021-07-161802.05CALL6 635.83FALSE2.050
2021-07-161850CALL 0FALSE00
2021-07-161900CALL 0FALSE00
2021-07-161950CALL 0FALSE00
2021-07-162000CALL 0FALSE00
2021-07-16601PUT5 20FALSE0.9415.67
2021-07-16652.57PUT4 40FALSE1.481.36
2021-07-16702.55PUT9 80FALSE0.010
2021-07-16753.61PUT2 10FALSE3.610
2021-07-16800.05PUT10 13547.7FALSE00
2021-07-16850PUT 0FALSE00
2021-07-16900PUT 0FALSE00
2021-07-16950PUT 0FALSE00
2021-07-161000PUT 53FALSE00
2021-07-161050PUT 47.69FALSE00
2021-07-161104PUT1 543.64FALSE0.60.18
2021-07-161157.5PUT1 637.1FALSE-1.4-0.16
2021-07-1612011.3PUT4 1532.16FALSE3.390.43
2021-07-1612512.76PUT10 2027.12FALSE12.760
2021-07-161302.2PUT1 2722.06FALSE-15.2-0.87
2021-07-161352.9PUT1 119.92FALSE2.90
2021-07-161404.9PUT1 118.76FALSE-18.92-0.79
2021-07-161450PUT 18.13TRUE00
2021-07-161507.82PUT1 217.74TRUE00
2021-07-161550PUT 16.88TRUE00
2021-07-1616014.5PUT1 116.04TRUE-0.3-0.02
2021-07-161650PUT 15.38TRUE00
2021-07-161700PUT 17.28TRUE00
2021-07-161750PUT 16.46TRUE00
2021-07-161800PUT 16.93TRUE00
2021-07-161850PUT 37.81TRUE00
2021-07-161900PUT 20.28TRUE00
2021-07-161950PUT 21.86TRUE00
2021-07-162000PUT 23.39TRUE00
2021-10-15650CALL 45.91TRUE00
2021-10-15700CALL 41.87TRUE00
2021-10-15750CALL 38.1TRUE00
2021-10-15800CALL 34.58TRUE00
2021-10-15850CALL 36.28TRUE00
2021-10-15900CALL 35.89TRUE00
2021-10-15950CALL 33.28TRUE00
2021-10-151000CALL 33.23TRUE00
2021-10-151050CALL 31.96TRUE00
2021-10-151100CALL 29.73TRUE00
2021-10-151150CALL 27.49TRUE00
2021-10-151200CALL 25.88TRUE00
2021-10-151250CALL 23.19TRUE00
2021-10-151300CALL 21.88TRUE00
2021-10-151350CALL 20.02TRUE00
2021-10-1514012.9CALL1 18.26TRUE12.90
2021-10-151450CALL 17.92FALSE00
2021-10-151500CALL 16.86FALSE00
2021-10-151555.7CALL1 216.12FALSE5.70
2021-10-151605.15CALL1 117.84FALSE5.150
2021-10-151650CALL 20.52FALSE00
2021-10-151700CALL 23.16FALSE00
2021-10-151750CALL 25.4FALSE00
2021-10-151801.4CALL4 327.59FALSE1.40
2021-10-151850CALL 30.21FALSE00
2021-10-151901.71CALL1 132.01FALSE1.710
2021-10-15650PUT 0FALSE00
2021-10-15700PUT 0FALSE00
2021-10-15750PUT 0FALSE00
2021-10-15800.15PUT530 7020FALSE0.150
2021-10-15850PUT 0FALSE00
2021-10-15900PUT 0FALSE00
2021-10-15950.2PUT1 445.23FALSE0.20
2021-10-151001.2PUT2 40.86FALSE1.20
2021-10-151050PUT 25.74FALSE00
2021-10-151100PUT 32.69FALSE00
2021-10-151159.8PUT2 228.61FALSE9.80
2021-10-151202.58PUT3 324.71FALSE2.580
2021-10-151253.13PUT3 322.08FALSE3.130
2021-10-151300PUT 19.59FALSE00
2021-10-151350PUT 19.17FALSE00
2021-10-151405PUT92 10417.7FALSE50
2021-10-151450PUT 16.59TRUE00
2021-10-151500PUT 16.11TRUE00
2021-10-151550PUT 15.61TRUE00
2021-10-151600PUT 15.05TRUE00
2021-10-1516521.7PUT2 213.77TRUE1.80.09
2021-10-151700PUT 13.91TRUE00
2021-10-151750PUT 15.26TRUE00
2021-10-151800PUT 13.51TRUE00
2021-10-151850PUT 14.86TRUE00
2021-10-151900PUT 16.17TRUE00

Latest PRAH Asks & Bids:

Date Shares Price Type
Mar 5, 2021 10:26 AM EST100$142.74Bid
Mar 5, 2021 9:30 AM EST700$151Ask
Mar 5, 2021 10:26 AM EST100$143.05Ask

Latest PRAH Trades:

Date Shares Price
Mar 5, 2021 10:23 AM EST100$142.45
Mar 5, 2021 10:25 AM EST100$142.6
Mar 5, 2021 10:25 AM EST100$142.71
Mar 5, 2021 10:25 AM EST200$142.67
Mar 5, 2021 10:26 AM EST100$143.07

PRA Health Sciences, Inc (PRAH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069440/0001104659-20-069440-index.htm
2018-10-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1613859/000000000018033979/0000000000-18-033979-index.htm
2018-11-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1613859/000000000018034843/0000000000-18-034843-index.htm
2019-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000008025519002969/0000080255-19-002969-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000008025520001277/0000080255-20-001277-index.htm
2018-02-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545718004721/0000215457-18-004721-index.htm
2018-06-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545718005685/0000215457-18-005685-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545719005002/0000215457-19-005002-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000083423719000382/0000834237-19-000382-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000083423720002824/0000834237-20-002824-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000090221920000201/0000902219-20-000201-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000093247118004056/0000932471-18-004056-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000093247119006033/0000932471-19-006033-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746918003013/0001047469-18-003013-index.htm
2018-08-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746918005435/0001047469-18-005435-index.htm
2018-08-08424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746918005508/0001047469-18-005508-index.htm
2019-03-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1613859/000104746919000948/0001047469-19-000948-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746919002379/0001047469-19-002379-index.htm
2019-09-04424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919004946/0001047469-19-004946-index.htm
2019-09-05424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919005017/0001047469-19-005017-index.htm
2019-09-13424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919005229/0001047469-19-005229-index.htm
2020-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746920002068/0001047469-20-002068-index.htm
2017-11-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465917065160/0001104659-17-065160-index.htm
2017-11-138-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917067943/0001104659-17-067943-index.htm
2017-11-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm
2017-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917074637/0001104659-17-074637-index.htm
2017-12-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917075713/0001104659-17-075713-index.htm
2018-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2018-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2018-04-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918024903/0001104659-18-024903-index.htm
2018-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465918025621/0001104659-18-025621-index.htm
2018-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918026604/0001104659-18-026604-index.htm
2018-05-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918029351/0001104659-18-029351-index.htm
2018-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918029352/0001104659-18-029352-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037085/0001104659-18-037085-index.htm
2018-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037121/0001104659-18-037121-index.htm
2018-05-31S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037123/0001104659-18-037123-index.htm
2018-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918038150/0001104659-18-038150-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918050976/0001104659-18-050976-index.htm
2018-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918052811/0001104659-18-052811-index.htm
2018-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm
2018-11-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1613859/000110465918066242/0001104659-18-066242-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465919022339/0001104659-19-022339-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm
2019-09-04FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919048481/0001104659-19-048481-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920017131/0001104659-20-017131-index.htm
2020-03-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920029723/0001104659-20-029723-index.htm
2020-04-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465920043152/0001104659-20-043152-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920052387/0001104659-20-052387-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064309/0001104659-20-064309-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064310/0001104659-20-064310-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064311/0001104659-20-064311-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064312/0001104659-20-064312-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064314/0001104659-20-064314-index.htm
2020-05-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920065894/0001104659-20-065894-index.htm
2020-05-26S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920065895/0001104659-20-065895-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069438/0001104659-20-069438-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069439/0001104659-20-069439-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069440/0001104659-20-069440-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920096108/0001104659-20-096108-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920096109/0001104659-20-096109-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920096111/0001104659-20-096111-index.htm
2020-09-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920105711/0001104659-20-105711-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920105715/0001104659-20-105715-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118007240/0001140361-18-007240-index.htm
2018-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118030961/0001140361-18-030961-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118030997/0001140361-18-030997-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119003050/0001140361-19-003050-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036120003236/0001140361-20-003236-index.htm
2019-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114420419047874/0001144204-19-047874-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001013/0001410578-19-001013-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001086/0001410578-19-001086-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001235/0001410578-19-001235-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284818000354/0001422848-18-000354-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284819000095/0001422848-19-000095-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284820000079/0001422848-20-000079-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385918000005/0001613859-18-000005-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385918000007/0001613859-18-000007-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000006/0001613859-19-000006-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/0001613859-19-000008-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000014/0001613859-19-000014-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000016/0001613859-19-000016-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000018/0001613859-19-000018-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000022/0001613859-19-000022-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000025/0001613859-19-000025-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000028/0001613859-19-000028-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000031/0001613859-19-000031-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000035/0001613859-19-000035-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000004/0001613859-20-000004-index.htm
2020-02-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/0001613859-20-000007-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000010/0001613859-20-000010-index.htm
2020-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000012/0001613859-20-000012-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000014/0001613859-20-000014-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000018/0001613859-20-000018-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000020/0001613859-20-000020-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000025/0001613859-20-000025-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000030/0001613859-20-000030-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000032/0001613859-20-000032-index.htm
2018-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018001965/0001628280-18-001965-index.htm
2018-02-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/0001628280-18-002026-index.htm
2018-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018004985/0001628280-18-004985-index.htm
2018-04-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000162828018005099/0001628280-18-005099-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018010186/0001628280-18-010186-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000162828018010277/0001628280-18-010277-index.htm

PRA Health Sciences, Inc (PRAH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PRA Health Sciences, Inc (PRAH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 24%
Institutional Ownership: 9891%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-12-28David W DockhornExecutive Vice President & CCOSell4,236.0091.22386,407.920.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOSell2,595.0090.56235,003.200.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2017-11-16Matthew P. YoungDirectorSell5,115.0079.90408,688.500.00https://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm
2018-06-21Jeffrey T BarberDirectorBuy1,307.0011,719.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm
2019-06-03Jeffrey T BarberDirectorBuy1,436.0013,155.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm
2019-08-13JAMES C MOMTAZEEDirectorBuy1,443.001,443.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm
2020-05-18Jeffrey T BarberDirectorBuy1,324.0014,479.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064312/0001104659-20-064312-index.htm
2020-08-13Michael J. BonelloEVP & CFOSell2,052.00102.88211,109.7621,276.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920096108/0001104659-20-096108-index.htm
2020-04-27Michael J. BonelloEVP & CFOSell3,672.0087.97323,025.8423,328.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920052387/0001104659-20-052387-index.htm
2018-06-21Alexander George DickinsonDirectorBuy1,307.002,397.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOSell64,405.0090.265,813,195.302,595.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2019-08-13Michael J. BonelloEVP & CFOBuy9,000.0027,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm
2019-09-06Fund Holdings L.P. KKR10% Share HolderSell6,666,684.0097.41649,401,688.4429,300.00https://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm
2019-09-06PRA Investors L.P. KKR10% Share HolderSell6,666,684.0097.41649,401,688.4429,300.00https://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm
2018-08-16COLIN SHANNONPresident & CEOBuy30,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm
2020-05-18JAMES C MOMTAZEEDirectorBuy1,748.003,191.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064311/0001104659-20-064311-index.htm
2020-08-13Christopher L GaenzleEVP, CAO & General CounselSell1,364.00102.88140,328.3237,636.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920096109/0001104659-20-096109-index.htm
2019-06-03Alexander George DickinsonDirectorBuy1,436.003,833.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm
2018-06-21Matthew P. YoungDirectorBuy1,307.004,117.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm
2017-12-28David W DockhornExecutive Vice President & CCOSell68,614.0090.816,230,837.344,236.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2020-05-18Alexander George DickinsonDirectorBuy1,324.005,157.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064314/0001104659-20-064314-index.htm
2019-06-03Matthew P. YoungDirectorBuy1,436.005,553.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm
2020-08-13COLIN SHANNONPresident & CEOSell6,073.00102.88624,790.2456,927.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920096111/0001104659-20-096111-index.htm
2019-08-13COLIN SHANNONPresident & CEOBuy33,000.0063,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm
2018-06-21Linda S GraisDirectorBuy1,307.006,673.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm
2018-08-09Fund Holdings L.P. KKR10% Share HolderSell6,500,000.00101.01656,565,000.006,695,984.00https://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm
2018-08-09PRA Investors L.P. KKR10% Share HolderSell6,500,000.00101.01656,565,000.006,695,984.00https://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOBuy67,000.0011.73785,910.0067,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2020-05-18Matthew P. YoungDirectorBuy1,324.006,877.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064309/0001104659-20-064309-index.htm
2017-12-28David W DockhornExecutive Vice President & CCOBuy72,850.0011.73854,530.5072,850.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2020-09-14Glen D. StettinDirectorBuy799.00799.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920105715/0001104659-20-105715-index.htm
2019-06-03Linda S GraisDirectorBuy1,436.008,109.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm
2020-05-18Linda S GraisDirectorBuy1,324.009,433.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064310/0001104659-20-064310-index.htm